Skip to main content
SpringerLink
Log in
Book cover

Depressive Disorders: Mechanisms, Measurement and Management pp 277–295Cite as

Potential Anti-Depressive Treatment Maneuvers from Bench to Bedside

  • Chapter
  • First Online:

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 1180))

Abstract

Numerous antidepressants are available for the treatment of the major depressive disorder (MDD). Unfortunately, the disadvantages of these antidepressive medications, including inadequate treatment response, the therapeutic lag between drug administration and the onset of symptoms alleviation, and the safety consideration limit their clinical use and accelerate the exploration of advanced antidepressants with novel action mechanisms/newer targets, with fewer side effects. In this chapter, a series of compounds showing clinical potent in the treatment of MDD has been reviewed based on their reported results from different phase clinical trials. Although the majority of these strategies currently only lead to a systematic approach in the aspects of treatment resistant depression, some of them would be a routine clinical practice which is usable in the treatment of MDD, such as ketamine. Additionally, beyond the mechanism of action for novel therapeutic molecules involving glutamatergic, opiate, cholinergic receptors, and neuroplasticity, some supplemental procedures such as polyunsaturated fatty acids were also included in this chapter due to their solid property against MDD.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Aan Het Rot M, Zarate CA Jr, Charney DS, Mathew SJ (2012) Ketamine for depression: where do we go from here? Biol Psychiatry 72(7):537–547

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Aaronson ST, Sears P, Ruvuna F et al (2017) A 5-year observational study of patients with treatment-resistant depression treated with vagus nerve stimulation or treatment as usual: comparison of response, remission, and suicidality. Am J Psychiatry 174(7):640–648

    Article  PubMed  Google Scholar 

  • Aizawa E, Tsuji H, Asahara T et al (2016) Possible association of Bifidobacterium and Lactobacillus in the gut microbiota of patients with major depressive disorder. J Affect Disord 202:254–257

    Article  PubMed  Google Scholar 

  • Alasfar F, Ben-Nakhi M, Khoursheed M, Kehinde EO, Alsaleh M (2011) Selenium is significantly depleted among morbidly obese female patients seeking bariatric surgery. Obes Surg 21(11):1710–1713

    Article  PubMed  Google Scholar 

  • Amsterdam JD, Kaplan M, Potter L, Bloom L, Rickels K (1986) Adinazolam, a new triazolobenzodiazepine, and imipramine in the treatment of major depressive disorder. Psychopharmacology 88(4):484–488

    Article  CAS  PubMed  Google Scholar 

  • Barragan-Rodriguez L, Rodriguez-Moran M, Guerrero-Romero F (2008) Efficacy and safety of oral magnesium supplementation in the treatment of depression in the elderly with type 2 diabetes: a randomized, equivalent trial. Magnes Res 21(4):218–223

    Google Scholar 

  • Berman RM, Cappiello A, Anand A et al (2000) Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 47(4):351–354

    Article  CAS  PubMed  Google Scholar 

  • Bikson M, Grossman P, Thomas C et al (2016) Safety of transcranial direct current stimulation: evidence based update 2016. Brain Stimul 9(5):641–661

    Google Scholar 

  • Blier P, Zigman D, Blier J (2012) On the safety and benefits of repeated intravenous injections of ketamine for depression. Biol Psychiatry 72(4):e11–12

    Article  CAS  PubMed  Google Scholar 

  • Blumberger DM, Vila-Rodriguez F, Thorpe KE et al (2018) Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomised non-inferiority trial. Lancet 391(10131):1683–1692

    Article  PubMed  Google Scholar 

  • Brunoni AR, Moffa AH, Sampaio-Junior B et al (2017) Trial of electrical direct-current therapy versus escitalopram for depression. N Engl J Med 376(26):2523–2533

    Article  CAS  Google Scholar 

  • Carhart-Harris RL, Goodwin GM (2017) The therapeutic potential of psychedelic drugs: past, present, and future. Neuropsychopharmacol: Off Publ Am Coll Neuropsychopharmacology 42(11):2105–2113

    Article  CAS  Google Scholar 

  • Carhart-Harris RL, Bolstridge M, Rucker J et al (2016) Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. Lancet Psychiatry 3(7):619–627

    Article  PubMed  Google Scholar 

  • Chilukuri H, Reddy NP, Pathapati RM, Manu AN, Jollu S, Shaik AB (2014) Acute antidepressant effects of intramuscular versus intravenous ketamine. Indian J Psychol Med 36(1):71–76

    Article  PubMed  PubMed Central  Google Scholar 

  • Dell’Osso B, Oldani L, Camuri G et al (2015) Augmentative repetitive transcranial magnetic stimulation (rTMS) in the acute treatment of poor responder depressed patients: a comparison study between high and low frequency stimulation. Eur Psychiatry: J Assoc Eur Psychiatrists 30(2):271–276

    Article  Google Scholar 

  • Diazgranados N, Ibrahim L, Brutsche NE et al (2010) A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression. Arch Gen Psychiatry 67(8):793–802

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Donde C, Amad A, Nieto I et al (2017) Transcranial direct-current stimulation (tDCS) for bipolar depression: a systematic review and meta-analysis. Prog Neuro-Psychopharmacol Biol Psychiatry 78:123–131

    Article  PubMed  Google Scholar 

  • Dos Santos RG, Balthazar FM, Bouso JC, Hallak JE (2016a) The current state of research on ayahuasca: a systematic review of human studies assessing psychiatric symptoms, neuropsychological functioning, and neuroimaging. J Psychopharmacol 30(12):1230–1247

    Article  CAS  PubMed  Google Scholar 

  • Dos Santos RG, Osorio FL, Crippa JA, Riba J, Zuardi AW, Hallak JE (2016b) Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years. Ther Adv Psychopharmacol 6(3):193–213

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Drevets WC, Furey ML (2010) Replication of scopolamine’s antidepressant efficacy in major depressive disorder: a randomized, placebo-controlled clinical trial. Biol Psychiatry 67(5):432–438

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Emadi-Kouchak H, Mohammadinejad P, Asadollahi-Amin A et al (2016) Therapeutic effects of minocycline on mild-to-moderate depression in HIV patients: a double-blind, placebo-controlled, randomized trial. Int Clin Psychopharmacol 31(1):20–26

    Article  PubMed  Google Scholar 

  • Fard FE, Mirghafourvand M, Mohammad-Alizadeh Charandabi S, Farshbaf-Khalili A, Javadzadeh Y, Asgharian H (2017) Effects of zinc and magnesium supplements on postpartum depression and anxiety: A randomized controlled clinical trial. Women Health 57(9):1115–1128

    Article  Google Scholar 

  • Fava M, McCall WV, Krystal A et al (2006) Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder. Biol Psychiatry 59(11):1052–1060

    Article  CAS  PubMed  Google Scholar 

  • Fond G, Hamdani N, Kapczinski F et al (2014) Effectiveness and tolerance of anti-inflammatory drugs’ add-on therapy in major mental disorders: a systematic qualitative review. Acta Psychiatr Scand 129(3):163–179

    Article  CAS  PubMed  Google Scholar 

  • Furey ML, Drevets WC (2006) Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized, placebo-controlled clinical trial. Arch Gen Psychiatry 63(10):1121–1129

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Griffiths RR, Johnson MW, Carducci MA et al (2016) Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial. J Psychopharmacol 30(12):1181–1197

    Article  CAS  PubMed  Google Scholar 

  • Grober U, Schmidt J, Kisters K (2015) Magnesium in prevention and therapy. Nutrients 7(9):8199–8226

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Hallahan B, Ryan T, Hibbeln JR et al (2016) Efficacy of omega-3 highly unsaturated fatty acids in the treatment of depression. Br J Psychiatry: J Ment Sci 209(3):192–201

    Article  Google Scholar 

  • Hanusch KU, Janssen CH, Billheimer D et al (2013) Whole-body hyperthermia for the treatment of major depression: associations with thermoregulatory cooling. Am J Psychiatry 170(7):802–804

    Article  PubMed  Google Scholar 

  • Hasler G, van der Veen JW, Tumonis T, Meyers N, Shen J, Drevets WC (2007) Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy. Arch Gen Psychiatry 64(2):193–200

    Article  CAS  PubMed  Google Scholar 

  • Heresco-Levy U, Gelfin G, Bloch B et al (2013) A randomized add-on trial of high-dose D-cycloserine for treatment-resistant depression. Int J Neuropsychopharmacol 16(3):501–506

    Article  CAS  Google Scholar 

  • Huang CC, Wei IH, Huang CL et al (2013) Inhibition of glycine transporter-I as a novel mechanism for the treatment of depression. Biol Psychiatry 74(10):734–741

    Article  CAS  PubMed  Google Scholar 

  • Husain MI, Chaudhry IB, Rahman RR et al (2015) Minocycline as an adjunct for treatment-resistant depressive symptoms: study protocol for a pilot randomised controlled trial. Trials 16:410

    Google Scholar 

  • Husain MI, Chaudhry IB, Hamirani MM et al (2017) Minocycline and celecoxib as adjunctive treatments for bipolar depression: a study protocol for a multicenter factorial design randomized controlled trial. Neuropsychiatr Dis Treat 13:1–8

    Article  Google Scholar 

  • Ibrahim L, Diazgranados N, Luckenbaugh DA et al (2011) Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major depression. Prog Neuro-Psychopharmacol Biol Psychiatry 35(4):1155–1159

    Article  CAS  PubMed  Google Scholar 

  • Ibrahim L, Diaz Granados N, Jolkovsky L et al (2012) A Randomized, placebo-controlled, crossover pilot trial of the oral selective NR2B antagonist MK-0657 in patients with treatment-resistant major depressive disorder. J Clin Psychopharmacol 32(4):551–557

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Iglesias P, Selgas R, Romero S, Diez JJ (2013) Selenium and kidney disease. J Nephrol 26(2):266–272

    Article  PubMed  CAS  Google Scholar 

  • Jain FA, Hunter AM, Brooks JO 3rd, Leuchter AF (2013) Predictive socioeconomic and clinical profiles of antidepressant response and remission. Depress Anxiety 30(7):624–630

    Article  CAS  PubMed  Google Scholar 

  • Janssen CW, Lowry CA, Mehl MR et al (2016) Whole-body hyperthermia for the treatment of major depressive disorder: a randomized clinical trial. JAMA Psychiatry 73(8):789–795

    Article  PubMed  Google Scholar 

  • Kantrowitz JT, Halberstam B, Gangwisch J (2015) Single-dose ketamine followed by daily D-Cycloserine in treatment-resistant bipolar depression. J Clin Psychiatry 76(6):737–738

    Google Scholar 

  • Kellner CH, Husain MM, Knapp RG et al (2016a) A novel strategy for continuation ECT in geriatric depression: phase 2 of the PRIDE study. Am J Psychiatry 173(11):1110–1118

    Article  PubMed  PubMed Central  Google Scholar 

  • Kellner CH, Husain MM, Knapp RG et al (2016b) Right unilateral ultrabrief pulse ECT in geriatric depression: phase 1 of the PRIDE study. Am J Psychiatry 173(11):1101–1109

    Article  PubMed  PubMed Central  Google Scholar 

  • Krystal JH, Madonick S, Perry E et al (2006) Potentiation of low dose ketamine effects by naltrexone: potential implications for the pharmacotherapy of alcoholism. Neuropsychopharmacol: Off Publ Am Coll Neuropsychopharmacology 31(8):1793–1800

    Article  CAS  Google Scholar 

  • Lai J, Moxey A, Nowak G, Vashum K, Bailey K, McEvoy M (2012) The efficacy of zinc supplementation in depression: systematic review of randomised controlled trials. J Affect Disord 136(1–2):e31–e39

    Article  CAS  PubMed  Google Scholar 

  • Lapidus KA, Levitch CF, Perez AM et al (2014) A randomized controlled trial of intranasal ketamine in major depressive disorder. Biol Psychiatry 76(12):970–976

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Larkin GL, Beautrais AL (2011) A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department. Int J Neuropsychopharmacol 14(8):1127–1131

    Article  CAS  Google Scholar 

  • Luscher B, Shen Q, Sahir N (2011) The GABAergic deficit hypothesis of major depressive disorder. Mol Psychiatry 16(4):383–406

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Marks DM, Abramowitz JS, Spielmans GI (2012) Concerns about data reporting and interpretation in “Efficacy and tolerability of the novel triple reuptake inhibitor amitifadine in the treatment of patients with major depressive disorder: a randomized, double-blind, placebo-controlled trial”. J Psychiatr Res 46(5):692–693; author reply 694–695

    Article  PubMed  Google Scholar 

  • Martins JG (2009) EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials. J Am Coll Nutr 28(5):525–542

    Article  CAS  PubMed  Google Scholar 

  • Meron D, Hedger N, Garner M, Baldwin DS (2015) Transcranial direct current stimulation (tDCS) in the treatment of depression: systematic review and meta-analysis of efficacy and tolerability. Neurosci Biobehav Rev 57:46–62

    Article  PubMed  Google Scholar 

  • Mion G, Villevieille T (2013) Ketamine pharmacology: an update (pharmacodynamics and molecular aspects, recent findings). CNS Neurosci & Ther 19(6):370–380

    Google Scholar 

  • Miyaoka T, Wake R, Furuya M et al (2012) Minocycline as adjunctive therapy for patients with unipolar psychotic depression: an open-label study. Prog Neuro-Psychopharmacol Biol Psychiatry 37(2):222–226

    Article  CAS  PubMed  Google Scholar 

  • Mokhber N, Namjoo M, Tara F et al (2011) Effect of supplementation with selenium on postpartum depression: a randomized double-blind placebo-controlled trial. J Matern-Fetal Neonatal Med: Off J Eur Assoc Perinat Med, Fed Asia Ocean Perinat Soc, Int Soc Perinat Obstet 24(1):104–108

    Article  Google Scholar 

  • Mrazek DA, Hornberger JC, Altar CA, Degtiar I (2014) A review of the clinical, economic, and societal burden of treatment-resistant depression: 1996–2013. Psychiatric Serv 65(8):977–987

    Article  PubMed  Google Scholar 

  • Mullard A (2016) Deuterated drugs draw heavier backing. Nat Rev Drug Discov 15(4):219–221

    Article  CAS  PubMed  Google Scholar 

  • Murrough JW, Perez AM, Pillemer S et al (2013) Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression. Biol Psychiatry 74(4):250–256

    Article  CAS  PubMed  Google Scholar 

  • Nemets H, Nemets B, Apter A, Bracha Z, Belmaker RH (2006) Omega-3 treatment of childhood depression: a controlled, double-blind pilot study. Am J Psychiatry 163(6):1098–1100

    Article  PubMed  Google Scholar 

  • Nitsche MA, Paulus W (2000) Excitability changes induced in the human motor cortex by weak transcranial direct current stimulation. J Physiol 527 Pt 3:633–639

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Osorio Fde L, Sanches RF, Macedo LR et al (2015) Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report. Revista brasileira de psiquiatria 37(1):13–20

    Article  Google Scholar 

  • Petty F, Trivedi MH, Fulton M, Rush AJ (1995) Benzodiazepines as antidepressants: does GABA play a role in depression? Biol Psychiatry 38(9):578–591

    Article  CAS  PubMed  Google Scholar 

  • Practice guideline for the treatment of patients with major depressive disorder (revision) (2000) American Psychiatric Association. Am J Psychiatry 157(4 Suppl):1–45

    Google Scholar 

  • Preskorn S, Macaluso M, Mehra DO et al (2015) Randomized proof of concept trial of GLYX-13, an N-methyl-D-aspartate receptor glycine site partial agonist, in major depressive disorder nonresponsive to a previous antidepressant agent. J Psychiatr Pract 21(2):140–149

    Article  PubMed  Google Scholar 

  • Raison CL, Hale MW, Williams LE, Wager TD, Lowry CA (2014) Somatic influences on subjective well-being and affective disorders: the convergence of thermosensory and central serotonergic systems. Front Psychol 5:1580

    Google Scholar 

  • Rasmussen KG, Lineberry TW, Galardy CW et al (2013) Serial infusions of low-dose ketamine for major depression. J Psychopharmacol 27(5):444–450

    Article  CAS  PubMed  Google Scholar 

  • Rayman M, Thompson A, Warren-Perry M et al (2006) Impact of selenium on mood and quality of life: a randomized, controlled trial. Biol Psychiatry 59(2):147–154

    Article  CAS  PubMed  Google Scholar 

  • Rice SM, Hickie IB, Yung AR et al (2016) Youth depression alleviation: the fish oil youth depression study (YoDA-F): a randomized, double-blind, placebo-controlled treatment trial. Early Interv Psychiatry 10(4):290–299

    Article  PubMed  Google Scholar 

  • Rolls ET, Grabenhorst F, Parris BA (2008) Warm pleasant feelings in the brain. NeuroImage 41(4):1504–1513

    Article  PubMed  Google Scholar 

  • Rush AJ, George MS, Sackeim HA et al (2000) Vagus nerve stimulation (VNS) for treatment-resistant depressions: a multicenter study. Biol Psychiatry 47(4):276–286

    Google Scholar 

  • Rush AJ, Trivedi MH, Wisniewski SR et al (2006) Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 163(11):1905–1917

    Article  PubMed  Google Scholar 

  • Salardini E, Zeinoddini A, Mohammadinejad P et al (2016) Riluzole combination therapy for moderate-to-severe major depressive disorder: a randomized, double-blind, placebo-controlled trial. J Psychiatr Res 75:24–30

    Article  PubMed  Google Scholar 

  • Sanacora G, Gueorguieva R, Epperson CN et al (2004) Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression. Arch Gen Psychiatry 61(7):705–713

    Article  CAS  PubMed  Google Scholar 

  • Sawada T, Yokoi K (2010) Effect of zinc supplementation on mood states in young women: a pilot study. Eur J Clin Nutr 64(3):331–333

    Article  CAS  PubMed  Google Scholar 

  • Segmiller F, Ruther T, Linhardt A et al (2013) Repeated S-ketamine infusions in therapy resistant depression: a case series. J Clin Pharmacol 53(9):996–998

    Google Scholar 

  • Shiroma PR, Johns B, Kuskowski M et al (2014) Augmentation of response and remission to serial intravenous subanesthetic ketamine in treatment resistant depression. J Affect Disord 155:123–129

    Article  CAS  PubMed  Google Scholar 

  • Short B, Fong J, Galvez V, Shelker W, Loo CK (2018) Side-effects associated with ketamine use in depression: a systematic review. Lancet Psychiatry 5(1):65–78

    Article  PubMed  Google Scholar 

  • Siwek M, Dudek D, Paul IA et al (2009) Zinc supplementation augments efficacy of imipramine in treatment resistant patients: a double blind, placebo-controlled study. J Affect Disord 118(1–3):187–195

    Article  CAS  PubMed  Google Scholar 

  • Steenbergen L, Sellaro R, van Hemert S, Bosch JA, Colzato LS (2015) A randomized controlled trial to test the effect of multispecies probiotics on cognitive reactivity to sad mood. Brain Behav Immun 48:258–264

    Article  PubMed  Google Scholar 

  • Su KP, Lai HC, Yang HT et al (2014) Omega-3 fatty acids in the prevention of interferon-alpha-induced depression: results from a randomized, controlled trial. Biol Psychiatry 76(7):559–566

    Article  CAS  PubMed  Google Scholar 

  • Szymkowicz SM, Finnegan N, Dale RM (2013) A 12-month naturalistic observation of three patients receiving repeat intravenous ketamine infusions for their treatment-resistant depression. J Affect Disord 147(1–3):416–420

    Article  CAS  PubMed  Google Scholar 

  • Tarleton EK, Littenberg B, MacLean CD, Kennedy AG, Daley C (2017) Role of magnesium supplementation in the treatment of depression: a randomized clinical trial. PloS One 12(6):e0180067

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Tiligada E, Kyriakidis K, Chazot PL, Passani MB (2011) Histamine pharmacology and new CNS drug targets. CNS Neurosci Ther 17(6):620–628

    Article  CAS  Google Scholar 

  • Tran P, Skolnick P, Czobor P et al (2012) Efficacy and tolerability of the novel triple reuptake inhibitor amitifadine in the treatment of patients with major depressive disorder: a randomized, double-blind, placebo-controlled trial. J Psychiatric Res 46(1):64–71

    Article  PubMed  Google Scholar 

  • Viereck V, Gamper M, Re: Kirchin V, Page T, Keegan PE, Atiemo KO, Cody JD, McClinton S, Aluko P (2017) Urethral injection therapy for urinary incontinence in women. Cochrane Database Syst Rev 7:CD003881. https://doi.org/10.1002/14651858.cd003881.pub4. Neurourol Urodyn 37(7):2286–2287

  • Ward SE, Bax BD, Harries M (2010) Challenges for and current status of research into positive modulators of AMPA receptors. Br J Pharmacol1 60(2):181–190

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Williams NR, Heifets BD, Blasey C et al (2018) Attenuation of antidepressant effects of ketamine by opioid receptor antagonism. Am J Psychiatry 175(12):1205–1215

    Article  Google Scholar 

  • Zarate CA Jr, Payne JL, Quiroz J et al (2004) An open-label trial of riluzole in patients with treatment-resistant major depression. Am J Psychiatry 161(1):171–174

    Article  PubMed  Google Scholar 

  • Zarate CA Jr, Singh JB, Carlson PJ et al (2006) A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 63(8):856–864

    Article  CAS  PubMed  Google Scholar 

  • Zarate CA Jr, Brutsche NE, Ibrahim L et al (2012) Replication of ketamine’s antidepressant efficacy in bipolar depression: a randomized controlled add-on trial. Biol Psychiatry 71(11):939–946

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zhang XL, Sullivan JA, Moskal JR, Stanton PK (2008) A NMDA receptor glycine site partial agonist, GLYX-13, simultaneously enhances LTP and reduces LTD at Schaffer collateral-CA1 synapses in hippocampus. Neuropharmacology 55(7):1238–1250

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, Xijing Hospital, Fourth Military Medical University, Xi’an, Shaanxi, China

    Min Cai & Huaning Wang

  2. Departments of Psychiatry and Cellular and Molecular Medicine, University of Ottawa, Institute of Mental Health Research at the Royal, Ottawa, ON, Canada

    Xia Zhang

Authors
  1. Min Cai
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Huaning Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xia Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Huaning Wang or Xia Zhang .

Editor information

Editors and Affiliations

  1. Division of Mood Disorders, Shanghai Mental Health Center, Shanghai, China

    Yiru Fang

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Cai, M., Wang, H., Zhang, X. (2019). Potential Anti-Depressive Treatment Maneuvers from Bench to Bedside. In: Fang, Y. (eds) Depressive Disorders: Mechanisms, Measurement and Management. Advances in Experimental Medicine and Biology, vol 1180. Springer, Singapore. https://doi.org/10.1007/978-981-32-9271-0_15

Download citation

Publish with us

Policies and ethics

Search

Navigation